RT-qPCR analyses in both EBV-negative and -positive epithelial tumor cells, as well as those cells with KDM5B knockdown or overexpression, pinpointed PLK2 as the primary target with the most significant alterations affected by KDM5B (Supplementary Fig. 4b–d). This evidence concerns the gene PLK2 and neoplasm.